Association between maternal cancer and the incidence of cancer in offspring.

in European journal of epidemiology by Su-Min Jeong, Jihye Heo, Kyujin Choi, Park Taegyun, Soo-Young Oh, Jonghan Yu, Danbee Kang

TLDR

  • The study found that offspring born to female cancer survivors have a higher risk of developing cancer compared to the general population.
  • The risk of cancer was found to be consistently high across various subgroups, including maternal age at delivery, maternal age at cancer diagnosis, and maternal cancer type.

Abstract

Despite the growing population of young cancer survivors of reproductive age, the risk of cancer in offspring born to female cancer survivors has yielded inconsistent results. Therefore, this study aimed to investigate the risk of cancer among the offspring of female cancer survivors by maternal age at delivery, maternal age at cancer diagnosis, maternal cancer type, and the time interval between cancer diagnosis and pregnancy. Using nationwide retrospective mother-child linked data from the Korean National Health Insurance Service, we included the first child (N = 8031) of female cancer survivors aged < 40 years after excluding thyroid cancer survivors and matched controls (N = 24,093) between 2005 and 2019. Subgroup analysis was performed according to maternal age at delivery, maternal age at cancer diagnosis, maternal cancer type, and the interval between cancer diagnosis and delivery. Among the offspring, 19 children of cancer survivors and 30 in the control group were diagnosed with cancer, with a mean age of 2.0 years at diagnosis. The most prevalent cancer type was leukemia (26.5%), followed by liver tumor (10.2%) and brain tumor (8.2%). The hazard ratio (HR) for cancer in the offspring of female cancer survivors was 1.91 (95% confidence interval (CI) = 1.07-3.38) demonstrating consistently high risk over the follow-up period. HRs for cancer risk in offspring were high across all subgroups despite the low statistical power. Our study indicated that offspring born to maternal cancer survivors had an increased risk of cancer.

Overview

  • This study investigated the risk of cancer in offspring born to female cancer survivors by examining several factors such as maternal age at delivery, maternal age at cancer diagnosis, maternal cancer type, and the time interval between cancer diagnosis and pregnancy.
  • The study used nationwide retrospective mother-child linked data from the Korean National Health Insurance Service and included the first child of female cancer survivors aged <40 years after excluding thyroid cancer survivors and matched controls.
  • The primary objective of the study was to examine the risk of cancer among the offspring of female cancer survivors and to determine whether certain factors were associated with an increased risk of cancer.

Comparative Analysis & Findings

  • Among the offspring, 19 children of cancer survivors and 30 in the control group were diagnosed with cancer, with a mean age of 2.0 years at diagnosis.
  • The hazard ratio (HR) for cancer in the offspring of female cancer survivors was 1.91 (95% confidence interval (CI) = 1.07-3.38), demonstrating a consistently high risk over the follow-up period.
  • HRs for cancer risk in offspring were high across all subgroups despite the low statistical power.

Implications and Future Directions

  • The study's findings indicated that offspring born to maternal cancer survivors have an increased risk of cancer, which has significant implications for reproductive counseling and cancer survivorship care.
  • Future research should aim to explore the potential biological mechanisms underlying this increased risk and to identify specific subgroups of cancer survivors at higher risk of transmitting cancer to their offspring.
  • Additionally, studies should examine the effects of maternal cancer treatment on the risk of cancer in offspring and investigate potential strategies for reducing this risk.